Reference values of galectin-3 and cardiac troponins derived from a single cohort of healthy blood donors

Clinica Chimica Acta

Volumn 456, Issue , 2016, Pages 19-23

  Mueller, Thomas ^a   Egger, Margot ^a   Leitner, Isabella ^a   Gabriel, Christian ^b   Haltmayer, Meinhard ^a   Dieplinger, Benjamin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Red Cross Transfusion Service of Upper Austria   (Austria)

Author keywords

Cardiac troponin; Evaluation study; Galectins; Natriuretic peptides; Reference values; Upper reference limits

Indexed keywords

GALECTIN 3; TROPONIN I; TROPONIN T;

ADULT; ANALYZER; ARTICLE; BLOOD DONOR; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GALECTIN 3 BLOOD LEVEL; HUMAN; LIMIT OF DETECTION; MALE; NONPARAMETRIC TEST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REFERENCE VALUE; SEX DIFFERENCE; TROPONIN I BLOOD LEVEL; TROPONIN T BLOOD LEVEL; BLOOD; BLOOD ANALYSIS; MIDDLE AGED; STANDARDS; YOUNG ADULT;

ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD DONORS; COHORT STUDIES; FEMALE; GALECTIN 3; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; TROPONIN I; TROPONIN T; YOUNG ADULT;

EID: 84959354298     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.02.014     Document Type: Article

References (30)

1. Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunol. Rev. 2009, 230:160-171.
2. Song L., Tang J.W., Owusu L., Sun M.Z., Wu J., Zhang J. Galectin-3 in cancer. Clin. Chim. Acta 2014, 431:185-191.
3. Ravani P., Barrett B.J. Galectin-3 and new-onset CKD: marker or mediator?. J. Am. Soc. Nephrol. 2013, 24:1342-1344.
4. Lippi G., Cervellin G. Risk assessment of post-infarction heart failure. Systematic review on the role of emerging biomarkers. Crit. Rev. Clin. Lab. Sci. 2014, 51:13-29.
5. Vasile V.C., Jaffe A.S. Emerging biomarkers for acute heart conditions. Curr. Opin. Cardiol. 2014, 29:312-318.
6. Yancy C.W., Jessup M., Bozkurt B., American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2013, 62:e147-e239.
7. Hickman P.E., Badrick T., Wilson S.R., McGill D. Reporting of cardiac troponin - problems with the 99th population percentile. Clin. Chim. Acta 2007, 381:182-183.
8. Collinson P.O., Heung Y.M., Gaze D., Boa F., Senior R., Christenson R., Apple F.S. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin. Chem. 2012, 58:219-225.
9. Koerbin G., Abhayaratna W.P., Potter J.M., Apple F.S., Jaffe A.S., Ravalico T.H., Hickman P.E. Effect of population selection on 99th percentile values for a high sensitivity cardiac troponin I and T assays. Clin. Biochem. 2013, 46:1636-1643.
10. Sandoval Y., Apple F.S. The global need to define normality: the 99th percentile value of cardiac troponin. Clin. Chem. 2014, 60:455-462.
11. Chaitman B.R. Is the 99th percentile the optimal reference limit to diagnose myocardial infarction with high-sensitivity cardiac troponin assays in patients with chronic kidney disease?. Circulation 2015, 131:2029-2031.
12. Wildi K., Gimenez M.R., Twerenbold R., Reichlin T., Jaeger C., Heinzelmann A., Arnold C., Nelles B., Druey S., Haaf P., Hillinger P., Schaerli N., Kreutzinger P., Tanglay Y., Herrmann T., Moreno Weidmann Z., Krivoshei L., Freese M., Stelzig C., Puelacher C., Rentsch K., Osswald S., Mueller C. Misdiagnosis of myocardial infarction related to limitations of the current regulatory approach to define clinical decision values for cardiac troponin. Circulation 2015, 131:2032-2040.
13. Apple F.S., Jaffe A.S., Collinson P., Mockel M., Ordonez-Llanos J., Lindahl B., Hollander J., Plebani M., Than M., Chan M.H., International Federation of Clinical Chemistry (IFCC) Task Force on Clinical Applications of Cardiac Bio-Markers IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin. Biochem. 2015, 48:201-203.
14. Giannitsis E. Sex-specific troponin measures for diagnosis of acute coronary syndrome. Heart 2016, 102:91-92.
15. Dieplinger B., Januzzi J.L., Steinmair M., Gabriel C., Poelz W., Haltmayer M., Mueller T. Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma - the Presage ST2 assay. Clin. Chim. Acta 2009, 409:33-40.
16. Clinical Laboratory Standards Institute Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, 3rd ed. EP28-A3c 2010, Clinical and Laboratory Standards Institute, Wayne, PA.
17. Giannitsis E., Kurz K., Hallermayer K., Jarausch J., Jaffe A.S., Katus H.A. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 2010, 56:254-261.
18. Apple F.S., Ler R., Murakami M.M. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin. Chem. 2012, 58:1574-1581.
19. Krintus M., Kozinski M., Boudry P., Capell N.E., Köller U., Lackner K., Lefèvre G., Lennartz L., Lotz J., Herranz A.M., Nybo M., Plebani M., Sandberg M.B., Schratzberger W., Shih J., Skadberg Ø., Chargui A.T., Zaninotto M., Sypniewska G. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin. Chem. Lab. Med. 2014, 52:1657-1665.
20. La'ulu S.L., Apple F.S., Murakami M.M., Ler R., Roberts W.L., Straseski J.A. Performance characteristics of the ARCHITECT Galectin-3 assay. Clin. Biochem. 2013, 46:119-122.
21. Gaze D.C., Prante C., Dreier J., Knabbe C., Collet C., Launay J.M., Franekova J., Jabor A., Lennartz L., Shih J., del Rey J.M., Zaninotto M., Plebani M., Collinson P.O. Analytical evaluation of the automated galectin-3 assay on the Abbott ARCHITECT immunoassay instruments. Clin. Chem. Lab. Med. 2014, 52:919-926.
22. Mueller T., Leitner I., Egger M., Haltmayer M., Dieplinger B. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. Clin. Chim. Acta 2015, 445:155-160.
23. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., Kusek J.W., Eggers P., Van Lente F., Greene T., Coresh J. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 2009, 150:604-612. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
24. de Boer R.A., van Veldhuisen D.J., Gansevoort R.T., Muller Kobold A.C., van Gilst W.H., Hillege H.L., Bakker S.J., van der Harst P. The fibrosis marker galectin-3 and outcome in the general population. J. Intern. Med. 2012, 272:55-64.
25. Ho J.E., Liu C., Lyass A., Courchesne P., Pencina M.J., Vasan R.S., Larson M.G., Levy D. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J. Am. Coll. Cardiol. 2012, 60:1249-1256.
26. Franzini M., Lorenzoni V., Masotti S., Prontera C., Chiappino D., Latta D.D., Daves M., Deluggi I., Zuin M., Ferrigno L., Mele A., Marcucci F., Caserta C.A., Surace P., Messineo A., Turchetti G., Passino C., Emdin M., Clerico A. The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: a multicenter study in Italy. Clin. Chim. Acta 2015, 438:376-381.
27. Korley F.K., Jaffe A.S. Preparing the United States for high-sensitivity cardiac troponin assays. J. Am. Coll. Cardiol. 2013, 61:1753-1758.
28. McGill D., Talaulikar G., Potter J.M., Koerbin G., Hickman P.E. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin. Chim. Acta 2010, 411:936-939.
29. Mansour M., Clark L., Kavsak P.A. Effect of freeze-thaw and refrigeration conditions on high-sensitivity troponin T concentrations. Ann. Clin. Biochem. 2012, 49:101-102.
30. Gillis J.M., Dunselman P., Jarausch J., de Jong N., Cobbaert C.M. Preanalytical storage does not affect 99th percentile cardiac troponin T concentrations measured with a high-sensitivity assay. Clin. Chem. 2013, 59:442-443.